BPGbio

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Phase 2Active, not recruiting202250 people12 Feb 2021clinicaltrials.gov

A Safety Study of Orally Administered BPM31510 in Healthy Subjects

Phase 1Completed201725 people26 Dec 2016clinicaltrials.gov

BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients

Phase 2Completed201645 people8 Jan 2016clinicaltrials.gov

A Safety Study of Orally Administered BPM31510 in Healthy Subjects

Phase 1Completed201520 people1 Jul 2015clinicaltrials.gov

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

Phase 1Completed201397 people8 Oct 2013clinicaltrials.gov

Mitochondrial dysfunction

15 Jul 2026bpgbio.com